Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-07-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12177 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849317871413362688 |
|---|---|
| author | Bradley Rockwell Mendel Goldfinger Ioannis Mantzaris Aditi Shastri Yogen Saunthararajah Kira Gritsman Alejandro R. Sica Noah Kornblum Nishi Shah David Levitz Lauren C. Shapiro Ridhi Gupta Anne Munoz Aradhika Dhawan Karen Fehn Monica Comas Jhannine Verceles Dennis L. Cooper Marina Konopleva Eric J. Feldman Amit Verma |
| author_facet | Bradley Rockwell Mendel Goldfinger Ioannis Mantzaris Aditi Shastri Yogen Saunthararajah Kira Gritsman Alejandro R. Sica Noah Kornblum Nishi Shah David Levitz Lauren C. Shapiro Ridhi Gupta Anne Munoz Aradhika Dhawan Karen Fehn Monica Comas Jhannine Verceles Dennis L. Cooper Marina Konopleva Eric J. Feldman Amit Verma |
| author_sort | Bradley Rockwell |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-050b3fddfcbf4fdfacd902c58801f5e2 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-050b3fddfcbf4fdfacd902c58801f5e22025-08-20T03:51:04ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-07-01999110.3324/haematol.2024.287253Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemiaBradley Rockwell0Mendel Goldfinger1Ioannis Mantzaris2Aditi Shastri3Yogen Saunthararajah4Kira Gritsman5Alejandro R. Sica6Noah Kornblum7Nishi Shah8David Levitz9Lauren C. Shapiro10Ridhi Gupta11Anne Munoz12Aradhika Dhawan13Karen Fehn14Monica Comas15Jhannine Verceles16Dennis L. Cooper17Marina Konopleva18Eric J. Feldman19Amit Verma20Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OHDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, BronxDepartment of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx Not available. https://haematologica.org/article/view/12177 |
| spellingShingle | Bradley Rockwell Mendel Goldfinger Ioannis Mantzaris Aditi Shastri Yogen Saunthararajah Kira Gritsman Alejandro R. Sica Noah Kornblum Nishi Shah David Levitz Lauren C. Shapiro Ridhi Gupta Anne Munoz Aradhika Dhawan Karen Fehn Monica Comas Jhannine Verceles Dennis L. Cooper Marina Konopleva Eric J. Feldman Amit Verma Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia Haematologica |
| title | Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| title_full | Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| title_fullStr | Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| title_full_unstemmed | Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| title_short | Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| title_sort | metronomic low dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia |
| url | https://haematologica.org/article/view/12177 |
| work_keys_str_mv | AT bradleyrockwell metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT mendelgoldfinger metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT ioannismantzaris metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT aditishastri metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT yogensaunthararajah metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT kiragritsman metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT alejandrorsica metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT noahkornblum metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT nishishah metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT davidlevitz metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT laurencshapiro metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT ridhigupta metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT annemunoz metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT aradhikadhawan metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT karenfehn metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT monicacomas metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT jhannineverceles metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT dennislcooper metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT marinakonopleva metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT ericjfeldman metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia AT amitverma metronomiclowdoseregimenofdecitabineandvenetoclaxissafeandreducesmonocyteburdeninchronicmyelomonocyticleukemia |